a study on Heart Failure
The purpose of this multicenter post-approval study is to evaluate the acute and chronic performance of the QuickFlex® μ 1258T left ventricular lead.
QuickFlex® μ Model 1258T Left Heart Pacing Lead Post Approval Study
The endpoints of the study are:
Heart Failure Left heart pacing lead Cardiac resynchronization therapy (CRT) Menthol
Open to people ages 18 years and up
© 2017 The Regents of the University of California